Zhou Shuchang, Zhu Tingting, Wang Yujing, Xia LiMing
Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095# Jiefang Jiefang Road, Qiaokou District, Wuhan, Hubei, China.
Eur Radiol. 2020 Oct;30(10):5446-5454. doi: 10.1007/s00330-020-06879-6. Epub 2020 May 4.
To investigate CT images of 100 confirmed COVID-19 pneumonia patients to describe the lesion distribution, CT signs, and evolution during different courses.
A retrospective study of 100 COVID-19 pneumonia patients without ARDS was performed, and CT scans were reviewed. A COVID-19 pneumonia course diagram was drawn. Mann-Whitney U test was used to compare the lesion distribution and CT scores, χ test was used to compare the CT findings between different stages.
A total of 272 CT scans from 100 patients (mean age, 52.3 years ± 13.1) were investigated. Four patients with lung abnormalities on CT first showed negative RT-PCR result and turned positive afterwards. One hundred sixty-nine (62.1%) showed predominantly peripheral distribution. The CT scores of the upper zone (3.4 ± 3.6) were significantly lower than those of the middle (5.0 ± 3.9) and lower (4.8 ± 3.6) zones (p < 0.001). The CT scores of the anterior zones (4.9 ± 4.7) were significantly lower than those of the posterior zones (8.4 ± 6.2) (p < 0.001). In the early rapid progressive stage (17 days), ground glass opacity (GGO) plus reticular pattern (58.1%), GGO plus consolidation (43.0%), and GGO (41.9%) were all common. In the advanced stage (814 days), GGO plus consolidation (79.8%) and repairing CT signs (subpleural line, bronchus distortion, and fibrotic strips) showed a significant increase (p < 0.05). In the absorption stage, GGO plus consolidation (9.1%) sharply decreased (p < 0.05).
CT imaging of COVID-19 pneumonia showed a predominantly peripheral, middle and lower, and posterior distribution. The early rapid progressive stage is 17 days from symptom onset, the advanced stage with peak levels of abnormalities on CT is 814 days, and the abnormalities started to improve after 14 days.
• The course of COVID-19 pneumonia consists of three stages: 17 days is the early rapid progressive stage, 814 days is the advanced stage, and after 14 days, the abnormalities started to decrease. • In the early rapid progressive stage, GGO plus a reticular pattern, GGO plus consolidation, and GGO were all common signs; in the advanced stage, signs of progression and absorption coexisted; lung abnormalities showed an asynchronous process with parts with absorption and parts progressing. • Lung abnormalities mainly showed predominantly peripheral, middle, and lower distribution.
研究100例确诊的新型冠状病毒肺炎患者的CT图像,以描述病变分布、CT征象及不同病程中的演变情况。
对100例无急性呼吸窘迫综合征的新型冠状病毒肺炎患者进行回顾性研究,并复查CT扫描结果。绘制新型冠状病毒肺炎病程图。采用曼-惠特尼U检验比较病变分布和CT评分,采用χ检验比较不同阶段的CT表现。
共对100例患者(平均年龄52.3岁±13.1岁)的272次CT扫描进行了研究。4例CT显示肺部异常的患者最初RT-PCR结果为阴性,随后转为阳性。169例(62.1%)主要表现为外周分布。上叶区域的CT评分(3.4±3.6)显著低于中叶(5.0±3.9)和下叶(4.8±3.6)区域(p<0.001)。前区的CT评分(4.9±4.7)显著低于后区(8.4±6.2)(p<0.001)。在早期快速进展期(17天),磨玻璃影(GGO)加网状影(58.1%)、GGO加实变(43.0%)和单纯GGO(41.9%)均较为常见。在进展期(814天),GGO加实变(79.8%)和修复性CT征象(胸膜下线、支气管扭曲和纤维条索)显著增加(p<0.05)。在吸收期,GGO加实变(9.1%)急剧下降(p<0.05)。
新型冠状病毒肺炎的CT影像主要表现为外周、中下叶及后区分布。早期快速进展期为症状出现后的17天,CT异常达到峰值的进展期为814天,14天后异常开始改善。
• 新型冠状病毒肺炎病程包括三个阶段:17天为早期快速进展期,814天为进展期,14天后异常开始减轻。• 在早期快速进展期,GGO加网状影、GGO加实变和单纯GGO均为常见征象;在进展期,进展和吸收征象并存;肺部异常呈异步过程,部分吸收,部分进展。• 肺部异常主要表现为外周、中下叶分布为主。